Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Biotech
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
The backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in the spotlight.
Nick Paul Taylor
Apr 18, 2024 8:34am
AbbVie grabs a wrench to add immunology-focused Landos Biopharma
Mar 25, 2024 9:20am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am
AbbVie drops MacroGenics-partnered ADC in light of early data
Mar 8, 2024 8:20am
AbbVie pays $48M for OSE's preclinical chronic inflammation drug
Feb 28, 2024 5:25am
AbbVie names CEO successor—Chutes & Ladders
Feb 23, 2024 9:30am